We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

Investopedia / Xiaojie Liu Form 1099-INT is an Internal Revenue Service (IRS) tax form used to report interest income. Form 1099-INT is issued by all entities that pay interest income to investors ...

So, when comparing Netflix Standard vs Premium, which is right for you? Below, we break down the pros and cons of the two pricier options. If you’re ready to sign up, you can do so by hitting ...

The therapy treats multiple myeloma. Credit: luchschenF/Shutterstock. Dr Reddy’s Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15, a ...

Google released Gemini 2.0 Flash for Google AI Studio and Vertex AI. The “Flash” in this model’s name means that it’s a model focused on speed. You’ll want to use this model if you want ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and this platform has helped it generate billions of dollars in ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare sector as a whole. This time last year, the biotech ...

Analyst Salveen Richter of Goldman Sachs maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), reducing the price target to $591.00. Leverage the power of TipRanks' Smart ...